Use

About 10–30% of patients continue with lingering symptoms four or more weeks after COVID‑19 infection, including those who had mild or no symptoms—termed post‑COVID conditions. The Centers for Disease Control (CDC) provide interim guidance for assessment and testing of patients with post‑COVID conditions. This panel is intended for use in evaluating persistent symptoms, 12 weeks or more post‑COVID, to assess coagulation status.

Not provided.